Wildcat Capital Management as of March 31, 2025
Portfolio Holdings for Wildcat Capital Management
Wildcat Capital Management holds 8 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Frontier Group Hldgs (ULCC) | 65.0 | $122M | 28M | 4.34 | |
| Rlx Technology Sponsored Ads (RLX) | 18.1 | $34M | 18M | 1.88 | |
| Acuren Corporation (TIC) | 8.9 | $17M | 1.5M | 11.12 | |
| Urogen Pharma (URGN) | 2.9 | $5.5M | 496k | 11.06 | |
| Allogene Therapeutics (ALLO) | 2.3 | $4.3M | 2.9M | 1.46 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.2 | $4.1M | 282k | 14.38 | |
| Kronos Bio | 0.6 | $1.1M | 1.3M | 0.82 | |
| Silexion Therapeutics Corp Shs New | 0.1 | $125k | 113k | 1.10 |
